Long-read sequencing of SARS-CoV-2 reveals novel transcripts and a diverse complex transcriptome landscape
This article has been Reviewed by the following groups
Listed in
- Evaluated articles (ScreenIT)
Abstract
Severe Acute Respiratory Syndrome Coronavirus 2, SARS-CoV-2 (COVID-19), is a positive single-stranded RNA virus with a 30 kb genome that is responsible for the current pandemic. To date, the genomes of global COVID-19 variants have been primarily characterized via short-read sequencing methods. Here, we devised a long-read RNA (IsoSeq) sequencing approach to characterize the COVID-19 transcript landscape and expression of its ∼27 coding regions. Our analysis identified novel COVID-19 transcripts including a) a short ∼65-70 nt 5’-UTR fused to various downstream ORFs encoding accessory proteins such as the envelope, ORF 8, and ORF 9 (nucleocapsid) proteins, that are relatively highly expressed, b) novel SNVs that are differentially expressed, whereby a subset are suggestive of partial RNA editing events, and c) SNVs at functional sites, whereby at least one is associated with a differentially expressed spike protein isoform. These previously uncharacterized COVID-19 isoforms, expressed genes, and gene variants were corroborated using ddPCR. Understanding this transcriptional complexity may help provide insight into the biology and pathogenicity of SARS-CoV-2 compared to other coronaviruses.
Article activity feed
-
SciScore for 10.1101/2021.03.05.434150: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Experimental Models: Cell Lines Sentences Resources Two SARS-CoV-2 RNA synthetic controls were utilized and run in parallel with the Pools A and B for this work: 1) a Twist Bioscience SARS-CoV-2 (MT199235 – USA/CA9/2020) synthetic control containing six non-overlapping 5 kb fragments and 2) SARS-CoV-2 RNAs isolated from Vero E6 mammalian cells transfected with a 30 kb cloned isolate (MN985325.1 −2019-nCoV/USA-WA1/2020) supplied by ATCC (ATCC® VR-1986D™). Vero E6suggested: None… SciScore for 10.1101/2021.03.05.434150: (What is this?)
Please note, not all rigor criteria are appropriate for all manuscripts.
Table 1: Rigor
Institutional Review Board Statement not detected. Randomization not detected. Blinding not detected. Power Analysis not detected. Sex as a biological variable not detected. Cell Line Authentication not detected. Table 2: Resources
Experimental Models: Cell Lines Sentences Resources Two SARS-CoV-2 RNA synthetic controls were utilized and run in parallel with the Pools A and B for this work: 1) a Twist Bioscience SARS-CoV-2 (MT199235 – USA/CA9/2020) synthetic control containing six non-overlapping 5 kb fragments and 2) SARS-CoV-2 RNAs isolated from Vero E6 mammalian cells transfected with a 30 kb cloned isolate (MN985325.1 −2019-nCoV/USA-WA1/2020) supplied by ATCC (ATCC® VR-1986D™). Vero E6suggested: NoneSoftware and Algorithms Sentences Resources The quality of the total RNA was tested using the Agilent Bioanalyzer 2100 Agilent Bioanalyzersuggested: NoneStringTie v2.1.4 usage included long reads processing (-L) which also enforces -s 1.5 -g 0 (default:false) and reference annotation (-G) used for guiding the assembly process (GTF/GFF3). StringTiesuggested: (StringTie , RRID:SCR_016323)Results from OddPub: We did not detect open data. We also did not detect open code. Researchers are encouraged to share open data when possible (see Nature blog).
Results from LimitationRecognizer: An explicit section about the limitations of the techniques employed in this study was not found. We encourage authors to address study limitations.Results from TrialIdentifier: No clinical trial numbers were referenced.
Results from Barzooka: We did not find any issues relating to the usage of bar graphs.
Results from JetFighter: We did not find any issues relating to colormaps.
Results from rtransparent:- Thank you for including a conflict of interest statement. Authors are encouraged to include this statement when submitting to a journal.
- No funding statement was detected.
- No protocol registration statement was detected.
-